[Text/Observer Network Long Yue] One week after the COVID-19 vaccination started, only 516 people in France completed the vaccination. Such "snail speed" has been severely criticized by French President Macron and others.

[Text/Observer Network Long Yue] One week after the COVID-19 vaccination started, only 516 people in France completed the vaccination. Such "snail speed" has been severely criticized by French President Macron and others.

According to the French "BFMTV" news channel on January 4, the leader of the left-wing "Indomitable French" party, Jean-Luc Mélenchon, posted on social media, expressing his dissatisfaction with the speed of vaccination.

Merangxiong called on France to purchase "traditional" vaccines from China, Russia and other countries, rather than relying solely on vaccines developed jointly by Pfizer, the United States and German biotech company BioNTech.

Mei Langxiong posted on social media

Reuters disclosed on the 4th that the Pfizer/BioNTech vaccine is the only new crown vaccine currently approved by the EU. On the 27th of last month, the EU officially started large-scale vaccination.

However, in Mei Langxiong's view, the Pfizer/BioNTech vaccine alone cannot speed up the vaccination work in France. He believes that France should promote "traditional vaccines".

Mei Langxiong said, "As far as I am concerned, I prefer traditional vaccines, which can achieve the high proportion of effectiveness required in the past. (We) can buy them from countries that produce this type of vaccine, such as China, Russia, Cuba and other countries." He also said that "traditional vaccines" are more realistic and sensitive in their application.

Public information shows that the vaccine developed by Moderna and Pfizer in the United States is an mRNA vaccine, which is a new type of vaccine. It is not as widespread in terms of application. The vaccine developed by China, such as Sinovac's "Kerryfor" vaccine, is an inactivated vaccine . This type of vaccine follows the traditional classic technology route and is widely used.

At the same time, Mei Langxiong believes that vaccination should follow the principle of voluntary treatment and “people should not be forced to choose the Pfizer vaccine.” He urged French vaccine research and development institutions to launch the country's own COVID-19 vaccine by spring this year.

Merangchen is a well-known French politician, 69 years old. On the 12th of last month, he announced that he would participate in the 2022 French presidential election, which is his third time running for president.

Mei Langxiong Video screenshot

Since the beginning of winter last year, the European epidemic has shown a rebound trend, and the current situation is still serious. According to the epidemic data statistics from , Johns Hopkins University in the United States, France has currently 2.71 million confirmed cases of new coronavirus pneumonia and 65,000 deaths.

The Chinese Embassy in France shows that on the 27th of last month, the French new crown vaccination was officially opened at the 93rd province of the Ile-de-France region and a senior medical center in Dijon. At 11 a.m. that day, a 78-year-old woman received her first shot. The French government plans to vaccinate 1 million elderly and medical staff in 7,000 nursing homes and elderly medical centers across France by the end of February this year.

However, the current vaccination rate of the new crown vaccine in France is extremely slow. Reuters said that the number of vaccinated people in the UK is close to 1 million, Germany is more than 200,000, and Italy is more than 100,000. But only 516 people were vaccinated in France in the first week. Former Director of the French General Administration of Health, Dabu, said bluntly, "At this rate, it will take 5,000 years for France to achieve its vaccination target."

Macron is very angry about this situation. He has been criticizing the progress of vaccination in private, saying that "the status quo must be changed quickly and effectively." According to "BFMTV", as the French government is questioned about vaccination, Macron has decided to hold a cabinet meeting on vaccination.

On the other hand, the process of the new crown vaccine developed by French companies is also very slow. According to the Russian Satellite News Agency, on the 11th of last month, the development of the new crown vaccine at Sanofi in France and GSK in the UK was delayed and is expected to be launched until later this year.

This article is an exclusive article by Observer.com and may not be reproduced without authorization.